For Immediate Release
Chicago, IL – April 7, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Teladoc Health, Inc. TDOC, Zoom Video Communications, Inc. ZM, Microsoft MSFT and Alphabet GOOGL.
Here are highlights from Monday’s Analyst Blog:
Coronavirus to Permanently Change Our Way of Life: 4 Trends
The catastrophic impact of the coronavirus pandemic on financial markets is being widely compared with the great financial crisis of 2008. Till now, this is yet to reach its peak in many big economies, which the researchers believe, will occur in the later part of April or beginning of May.
Meanwhile, a recent statement by the IMF, that the impact will be way worse than 2008, has all the more jeopardized investors, compelling them to remain in the sell-off territory.
Whether or not the situation will take a graver turn, it is quite definite that the coronavirus-led devastation is hugely potent to alter the economy as a whole. Here we are talking about the consumption-spending pattern of a rational individual, as well as of the entire social paradigm. Precisely, this can be change in hygiene sense, eating habit, spending on luxury items, leisurely travel, religious inclination, and over and above notion of livelihood and lifestyle.
From an investor’s point of view, it is essential to understand this transformation and shape one’s portfolio according to the shifting trends. However, the question that comes to our minds is whether to transform the entire equity portfolio or wait for the perfect time. But again, when is that perfect time and how would an investor know it has come?
As Jim Cramer says, "I love behavior-change investing. It can be incredibly lucrative, and when you have a behavior-change theme you can use selloffs to pick stocks based on those changes."
It's a huge opportunity out there and being myopic just won't work. A farsightedness is needed to reap the reward of this gain game.
Four Major Trend Shits to Focus On
Already a lot has been said on the growing prosperity of the telemedicine sector over the past three months as a major choice for contactless healthcare services. Despite the U.S. government’s measures to make telemedicine mainstream for the past few years, primarily to minimize healthcare cost and increase access of care, the sector was yet to receive mass acceptance. Nevertheless, post the COVID-19 outbreak, the situation has drastically changed.
Telemedicine stocks received an impressive response, when in February, the Centers for Disease Control and Prevention asked healthcare service communities to increase the use of telemedicine in broader ways. Added to this, the House passed an emergency spending bill, allowing medicare reimbursement for telehealth during crisis situations.
We believe, even when normalcy resumes, the telemedicine stocks will keep gaining good reception banking on change in consumer spending toward more contactless services. Going by a Nielsen investigation's report, there will be Proactive Health-Minded Buying with consumer interest growing toward products that support overall maintenance of health and wellness. Here we ask investors to keep an eye on telemedicine stocks like Teladoc Health, Inc. The stock currently carries a Zacks Rank #3 (Hold).
With consumers unable to venture outdoors now, another thing that is changing from the core is the concept of education. Schools, universities as well as other learning institutes shutting down one after another for indefinite time period are dragging the future of millions of children into murkier waters. This is forcing the education system to widely call for the learn-from-home concept. While e-learning can never substitute classroom teaching, many economists believe this virtual delivery of education, which has become a necessity now, will not fade away even after the mayhem disappears.
Meanwhile, according to Forbes (published in Fatbit Technologies article), the worldwide e-learning market is projected to be worth $325 billion in 2025. Here we ask investors to focus on Chegg, Inc. and Zoom Video Communications, Inc., both carrying a Zacks Rank of 2 (Buy), with stellar growth prospects. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the meantime, during such unprecedented times, digital communication stocks are grabbing attention, with global corporations having no other options but to allow mass work from home for employees. Going by a Statisrta data, during a March 2020 survey, 32% of 18-29 year age group in the United States stated that they had used the internet for video calling or conferencing services to attend a work meeting. This was 33% for the age group of 30-49.
This overnight transformation of the work-life concept has popularized digital communication stocks. On Mar 19, Microsoft noted that its group chat and collaboration software — Team — has registered a 500% spike in usage since Jan 31. Further, Alphabet division Google’s android video-calling app, Duo, has increased its group calling video limit. These two stocks carry a Zacks Rank #3, at present.
Another sector that has already started to gain significance amid current turbulence is e-commerce. With restaurants and supermarkets remaining closed, consumers are fast shifting from offline to online shopping. A Digital Commerce 360 report states that the pandemic-led crisis will provide a long-term boost for online retailers — if they can survive through the short-term turmoil that is hurting overall economic health. Amish Jani, a partner at venture capital firm FirstMark, believes in the long term, online shopping will get a boost from the lifestyle changes currently being forced on consumers. And this change will be enduring.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Microsoft Corporation (MSFT): Free Stock Analysis Report
Alphabet Inc. (GOOGL): Free Stock Analysis Report
Teladoc Health, Inc. (TDOC): Free Stock Analysis Report
Zoom Video Communications, Inc. (ZM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.